Ganga Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 ,inter alia, to consider and approve Audited Financial Results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ganga Pharmaceuticals has informed BSE that its Board of Directors will meet on Tuesday, May 20, 2025, to consider and approve the Audited Financial Results for the half-year and full financial year ended March 31, 2025. The filing is made in compliance with SEBI Listing Regulations. The trading window for dealing in company securities has been closed since April 1, 2025, for all designated persons and will reopen 48 hours after the results are announced. No actual financial figures or outcomes have been disclosed in this filing.
This is a routine regulatory intimation with no material impact on shareholders at this stage. Investors should watch for the actual audited results on May 20, 2025, which may influence the stock price depending on the financial performance disclosed.